GenMont Biotech Incorporation

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Rok finansowy 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 353 515 286 227 309 565 535 541 553 407 346 325 428 369 318 385
Przychód Δ r/r 0.0% 45.8% -44.4% -20.8% 36.2% 82.7% -5.3% 1.1% 2.2% -26.5% -14.8% -6.1% 31.6% -13.9% -13.7% 21.2%
Marża brutto 80.0% 76.5% 67.0% 63.6% 69.3% 44.9% 51.1% 57.3% 58.2% 68.3% 66.3% 66.2% 69.9% 69.7% 55.8% 61.8%
EBIT (mln) 96 157 -17 -29 57 -144 -46 -18 27 123 75 77 143 65 7 40
EBIT Δ r/r 0.0% 62.8% -110.6% 74.2% -296.4% -353.7% -68.2% -60.6% -247.3% 360.4% -38.6% 2.0% 86.4% -54.5% -89.3% 474.1%
EBIT (%) 27.3% 30.4% -5.8% -12.8% 18.4% -25.6% -8.6% -3.3% 4.8% 30.2% 21.8% 23.7% 33.5% 17.7% 2.2% 10.4%
Koszty finansowe (mln) 0 0 8 9 23 10 0 0 0 0 1 1 1 1 1 4
EBITDA (mln) 122 186 3 1 78 -267 12 70 66 151 97 98 165 116 72 140
EBITDA(%) 34.7% 36.1% 1.0% 0.4% 25.1% -47.2% 2.3% 12.9% 12.0% 37.0% 27.9% 30.1% 38.5% 31.4% 22.6% 36.3%
Podatek (mln) 11 8 5 14 6 5 14 16 -14 26 18 17 30 19 6 17
Zysk Netto (mln) 86 148 38 29 31 -386 -98 -236 46 158 57 61 113 57 33 57
Zysk netto Δ r/r 0.0% 71.1% -74.1% -24.3% 6.9% -1350.1% -74.6% 140.7% -119.3% 246.5% -63.6% 6.0% 85.8% -49.6% -42.1% 73.5%
Zysk netto (%) 24.4% 28.7% 13.3% 12.7% 10.0% -68.4% -18.3% -43.6% 8.2% 38.9% 16.6% 18.7% 26.4% 15.5% 10.4% 14.9%
EPS 1.62 2.78 0.72 0.52 0.51 -5.82 -1.1 -2.65 0.51 1.78 0.65 0.69 1.31 0.66 0.38 0.66
EPS (rozwodnione) 1.62 2.78 0.72 0.52 0.51 -5.82 -1.1 -2.65 0.51 1.77 0.64 0.69 1.3 0.66 0.38 0.66
Ilośc akcji (mln) 53 53 53 55 61 66 89 89 89 89 89 88 86 86 86 87
Ważona ilośc akcji (mln) 53 53 53 55 61 66 89 89 89 89 89 88 87 87 87 87
Waluta TWD TWD TWD TWD TWD TWD TWD TWD TWD TWD TWD TWD TWD TWD TWD TWD